Could your genes decide when you get a mammogram? major study tests personalized breast cancer screening
NCT ID NCT03672331
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing whether a breast cancer screening plan based on each woman's personal risk (using clinical factors and genetic markers) works better than the standard schedule. Over 53,000 women aged 40-70 are being randomly assigned to either risk-based or standard screening for 4 years. The goal is to see if the personalized approach reduces the number of advanced (stage 2 or higher) breast cancers detected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that tailoring screening to a woman's personal risk is better than a one-size-fits-all approach, potentially reducing advanced breast cancers.
What could go wrong
This is a large study, but results are not yet available. The personalized strategy may not prove superior, and risk assessment tools may not be accurate for all women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AUSL Reggio Emilia
Reggio Emilia, Emilia-Romagna, Italy
-
Assuta Medical Center Ramat HaHayal
Tel Aviv, Israel
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, United Kingdom
-
Gustave roussy
Villejuif, France
-
Institut Jules Bordet
Brussels, Belgium
-
Marta Romản
Barcelona, Spain